Reuters logo
BRIEF-Nektar Therapeutics reports Q3 earnings per share $0.39
November 7, 2017 / 9:17 PM / 18 days ago

BRIEF-Nektar Therapeutics reports Q3 earnings per share $0.39

Nov 7 (Reuters) - Nektar Therapeutics:

* Nektar Therapeutics reports financial results for the third quarter of 2017

* Q3 earnings per share $0.39

* Q3 revenue $152.9 million versus $36.3 million

* Q3 revenue view $114.6 million -- Thomson Reuters I/B/E/S

* Q3 earnings per share view $0.17 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below